Introduction
============

Stroke, universally acknowledged as a cerebrovascular accident, may result in lasting brain damage, long-term disability or even mortality ([@b1-mmr-20-01-0417],[@b2-mmr-20-01-0417]). A multitude of biological processes are implicated in ischemic stroke, including oxygen deprivation, neuronal necrosis and an intense inflammatory response ([@b3-mmr-20-01-0417],[@b4-mmr-20-01-0417]). MicroRNAs (miRNAs), long non-coding RNAs (lncRNAs) and even circular RNAs (circRNAs) contribute to RNA-mediated networks ([@b5-mmr-20-01-0417]--[@b8-mmr-20-01-0417]) that regulate notable cellular events through a variety of complicated mechanisms ([@b9-mmr-20-01-0417],[@b10-mmr-20-01-0417]). These networks have been implicated in ischemic stroke in previous studies ([@b5-mmr-20-01-0417]--[@b10-mmr-20-01-0417]); however, there remain gaps in current knowledge in this regard, and novel ncRNAs need be mined in order to provide a better understanding of the precise molecular mechanisms involved in ischemic stroke.

lncRNAs have been proven to be critical gene regulators of development and disease ([@b11-mmr-20-01-0417]--[@b13-mmr-20-01-0417]). lncRNAs may also perform functions through competitively binding to miRNAs known as competitive endogenous RNAs ([@b14-mmr-20-01-0417]). Washietl *et al* ([@b15-mmr-20-01-0417]) systematically analyzed the conservatism of human lncRNA and other six mammalian lncRNA and identified that \~54% human lncRNA loci may be mapped to that of a rat. A previous study has demonstrated that significantly differentially expressed lncRNAs (DELs) may contribute to the stabilization of mRNA expressions in stroke ([@b7-mmr-20-01-0417]). Stroke-induced lncRNAs may also interact with chromatin-modifying proteins and modulate genes associated with ischemic brain damage ([@b16-mmr-20-01-0417],[@b17-mmr-20-01-0417]). Furthermore, lncRNA BC088414 was revealed to be involved with apoptosis-associated genes following hypoxic-ischemic brain damage ([@b8-mmr-20-01-0417]). Similarly, another study suggested that lncRNA C2dat1 may modulate calcium/calmodulin-dependent protein kinase II expression to promote neuronal survival following cerebral ischemia ([@b10-mmr-20-01-0417]). Although a host of lncRNAs have been identified by massive parallel sequencing, to date, little is known on functional RNA molecules and RNA-mediated regulation networks in ischemic stroke.

The main aim of the present study is to elucidate the lncRNA-mRNA regulation networks in ischemic stroke induced by middle cerebral artery occlusion (MCAO) using RNA sequencing (RNA-seq) in rats.

Materials and methods
=====================

### MCAO model and tissue preparation

A focal cerebral ischemia model induced by MCAO, prepared as previously described ([@b18-mmr-20-01-0417]), was prepared using 20 7-week-old male Sprague-Dawley rats of a specific pathogen-free grade (weighing 200±20 g), purchased from the experimental animal center of Anhui Medical University (Anhui, China). The study protocol was ethically approved by the Committee on the Ethics of Animal Experiments of Anhui University of Chinese Medicine (approval no. 2012AH-036-03). In brief, the animals were fasted overnight but allowed *ad libitum* access to water. They were then anesthetized with chloral hydrate (350 mg/kg, intraperitoneal injection). A 4-0 silicon-coated monofilament nylon suture with a round tip was inserted through an arteriectomy in the common carotid artery just below the carotid bifurcation and then advanced into the internal carotid artery \~18 mm distal to the carotid bifurcation until a mild resistance was felt. Following 2 h of MCAO, the filament was removed to allow reperfusion. As a control, control-operated rats underwent identical surgery but did not have the suture inserted. Four days subsequent to MCAO, the left hemispheres were collected and immediately frozen in liquid nitrogen.

### RNA-seq

RNA-seq was performed by Ao-Ji Bio-Tech (Shanghai, China). Briefly, total RNA was extracted using an RNeasy Mini kit (Qiagen GmbH, Hilden, Germany), according to the manufacturer\'s protocol. The RNA quality control was performed using Nanodrop 2000 and Agilent 2100, and mainly depended on the concentration, purity and integrity of the RNA. Ribosomal RNA was removed from total RNA using Ribo-Zero rRNA removal beads (Illumina, Inc., San Diego, CA, USA). Libraries were constructed according to the standard TruSeq protocol ([@b19-mmr-20-01-0417]). Purified cDNA libraries were prepared for cluster generation and sequencing on an Illumina HiSeq 2500 (Illumina, Inc.) according to the manufacturer\'s protocol. Subsequently, data analyses were performed *in silico*.

### lncRNA annotation

Quality control of the RNA-Seq reads was conducted using FastQC (v0.11.3) (The Babraham Institute, Cambridge, UK). Reads were trimmed using the software seqtk ([github.com/lh3/seqtk](github.com/lh3/seqtk)) for known Illumina TruSeq adapter sequences, poor reads and ribosome RNA reads. Trimmed reads were aligned to the rat genome (Rn6) using Hisat2 (version 2.0.4) ([@b20-mmr-20-01-0417]). Transcripts were assembled using Stringtie (v1.3.0) ([@b20-mmr-20-01-0417],[@b21-mmr-20-01-0417]). Transcripts constructed from Stringtie were compiled together by gffcompare (v0.9.8) ([@b20-mmr-20-01-0417],[@b21-mmr-20-01-0417]). Transcripts detected in at least five samples (half of the total number) were considered to be bona fide transcripts. Transcripts, with the exception of those with just one exon and shorter than 200 base pairs, were further analyzed for the identification of lncRNAs. Transcripts with class codes 'i,' 'u,' and 'x,' were considered to be potential novel long transcripts. Pfam ([@b22-mmr-20-01-0417]), Coding Potential Calculator (CPC) ([@b23-mmr-20-01-0417]) and Coding-Non-Coding Index (CNCI) ([@b24-mmr-20-01-0417]) were used to estimate the coding potential of each novel transcript. Transcripts with a Pfam score \<0, CNCI \<0 and CPC non-significant were considered to lack coding potential. Transcripts were compared with annotation databases, including NONCODE (v4) (<http://www.noncode.org>) and Ensembl ([@b25-mmr-20-01-0417]). The matched transcripts were considered to be known lncRNAs, and others were considered to be novel lncRNAs. All lncRNAs were quantified using Stringtie. According to the positional association between lncRNA and mRNA in the genome, lncRNA may be classified into six types: Bidirectional, exonic_antisense, exonic_sense, intergenic, intronic_antisense and intronic_sense ([@b26-mmr-20-01-0417]).

### The lncRNA-mRNA coexpression network

Initially, the DELs and differentially expressed genes (DEGs) were analyzed using EdgeR ([@b27-mmr-20-01-0417]). For DEGs, log2\| \[fold change (FC)\] \|\>1 and P\<0.05 were used as the cutoff values. Meanwhile, log2\| (FC) \|\>1 and false discovery rate (FDR) \<0.05 were used as the threshold for DELs. Hierarchical clustering of DELs was performed based on mean signals using a Euclidean distance function. In addition, a volcano plot was generated. The Pearson\'s correlation coefficient (PCC) between lncRNAs and mRNAs was calculated (cutoff value, PCC\>0.9, P\<0.05) and the lncRNA-mRNA regulatory network was structured using Cytoscape 2.8.3 ([@b28-mmr-20-01-0417]).

### Prediction of target genes and enrichment analysis

*cis*- or *trans*-acting algorithms were used to predict the potential targets of lncRNAs. The first algorithm predicted potential target genes of *cis*-acting lncRNAs that were physically located within 10 kb upstream or 20 kb downstream of lncRNAs using liftOver genome browser ([genome.ucsc.edu/cgi-bin/hgLiftOver](genome.ucsc.edu/cgi-bin/hgLiftOver)). The second algorithm predicted potential target genes of *trans*-acting lncRNAs based on the lncRNA-mRNA complementary sequences, and predicted lncRNA-mRNA duplex energy. First, BLASTN ([@b29-mmr-20-01-0417]) was performed to detect potential target mRNA sequences with \>95% identity and E value \<1×10^−5^ (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>). Then, RNAplex ([@b30-mmr-20-01-0417]) was used to calculate the complementary energy between lncRNAs and their potential *trans*-regulated target genes with RNAplex-10^−30^. Gene Ontology (GO) ([@b31-mmr-20-01-0417]) and Kyoto Encyclopedia of Genes and Genomes (KEGG) ([@b32-mmr-20-01-0417]) enrichment analyses of the identified potential target genes were performed using the Database for Annotation, Visualization and Integrated Discovery ([@b33-mmr-20-01-0417]); and P\<0.05 was considered to indicate a statistically significant difference.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Total RNA was extracted from left hemisphere samples using TRIzol^®^ reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and reverse-transcribed using a Thermo Fisher Scientific RevertAid First Strand cDNA Synthesis kit (cat. no. K1622; Thermo Fisher Scientific, Inc.) according to the manufacturer\'s protocol at 42°C for 60 min. To further confirm the expression data from RNA-seq, a cutoff value (FC\>2, P\<0.05) was randomly selected for qPCR verification. The expression levels of six randomly DELs (NONRATT027551.2, MSTRG.1836.1, MSTRG.4344.10, MSTRG.7720.11, NONRATT005132.2 and MSTRG.20633.3) were assayed using a SYBRGreen flurophore (Applied Biosystems; Thermo Fisher Scientific, Inc.) using the PikoReal real-time PCR system (Thermo Fisher Scientific, Inc.) under the following conditions: Initial denaturation at 95°C for 30 sec, followed by 40 cycles at 95°C for 30 sec and 60°C for 30 sec, and a final extension step at 4°C for 20 min. FC was determined using the 2^−ΔΔCq^ method ([@b34-mmr-20-01-0417]). GAPDH mRNA was used as an internal control. The primers used are listed in [Table I](#tI-mmr-20-01-0417){ref-type="table"}.

### Statistical analysis

The comparisons between the MCAO group and the control group were determined using a Student\'s t-test for the RT-qPCR results by SPSS 22.0 statistical software (IBM Corp., Armonk, NY, USA). P\<0.05 was considered to indicate a statistically significant difference. The PCC between lncRNAs and mRNAs was calculated using the Hmisc package in R based on the expression determined using RNA-seq (PCC\>0.9, P\<0.05). The correlation analysis between the RT-qPCR results and RNA-seq results was calculated in Excel 2013 (Microsoft Corporation, Redmond, WA, USA) with the function of CORR.

Results
=======

### lncRNA-sequencing data analysis

The present study characterized the lncRNA landscape and expression by performing deep RNA-seq experiments on three control and three MCAO tissue samples. Subsequent to the seqtk quality assessment of sequencing, \>33 million total original reads for each sample were obtained, and the proportion of bases with quality values \>20 was \>94%. These results indicated that the quality of the sequencing results was acceptable ([Table II](#tII-mmr-20-01-0417){ref-type="table"}). Subsequent to filtering out the adaptor sequence and low quality reads, the percentage of clean reads within the raw reads accounted for 94% of the total sequences in two groups. Hisat2 software was used to map the obtained clean reads to the *Rattus norvegicus* reference genome. As presented in [Table II](#tII-mmr-20-01-0417){ref-type="table"}, \~97% of the trimmed reads were mapped onto the reference genome. In total, 24,304 lncRNAs were screened from six samples, and there were 23,255 shared lncRNAs detected in the MCAO and control groups ([Fig. 1A](#f1-mmr-20-01-0417){ref-type="fig"}). The majority of the identified lncRNAs were transcribed from protein-coding exons; others were from introns and intergenic regions ([Fig. 1B](#f1-mmr-20-01-0417){ref-type="fig"}). In addition, the present study analyzed the distribution of the identified lncRNAs on the rat chromosomes; 24,304 lncRNA transcripts were identified in all chromosomes, and chromosome 1 included the most lncRNAs ([Fig. 1C](#f1-mmr-20-01-0417){ref-type="fig"}).

### Identification of DEGs and DELs

EdgeR was used to filter DEGs and DELs and differentiate their expression between the control and MCAO groups. A total of 1,007 DEGs (\|FC\|\>2, P\<0.05) were identified, including 785 upregulated genes and 222 downregulated genes. Similarly, as presented in [Fig. 2](#f2-mmr-20-01-0417){ref-type="fig"}, 134 DELs (\|FC\|\>2, FDR\<0.05) were identified in the MCAO group ([Fig. 2A and B](#f2-mmr-20-01-0417){ref-type="fig"}), including 77 upregulated and 57 downregulated DELs ([Fig. 2C and D](#f2-mmr-20-01-0417){ref-type="fig"}). In the present study, it was revealed that the FC values of certain DELs were equal to positive infinity and negative infinity, meaning that these lncRNAs are switched-on or off with MCAO. Essentially, positive or negative infinity indicates zero expression of the lncRNA in normal or MCAO groups. It was speculated that this may be associated with the abundance of lncRNAs and the sensitivity to RNA-seq. The top five upregulated DELs were NONRATT027551.2, MSTRG.1836.1, MSTRG.4344.10, NONRATT028102.2 and MSTRG.31500.2; the top five downregulated DELs were MSTRG.7720.11, NONRATT005132.2, MSTRG.20633.3, NONRATT020232.2 and MSTRG.1836.3.

### lncRNA-mRNA network

The cutoff correlation r-values (\|PCC\|\>0.9) and P-values (P\<0.05) were selected to structure a lncRNA-mRNA co-expression network between DEGs and DELs. As [Fig. 3](#f3-mmr-20-01-0417){ref-type="fig"} presents, 46 DEGs, 104 DELs and 664 edges were filtered out using Cytoscape to construct the co-expression network. The co-expression-associated top 30 GO terms and pathway terms enrichment analyses presented in [Figs. 4](#f4-mmr-20-01-0417){ref-type="fig"} and [5](#f5-mmr-20-01-0417){ref-type="fig"} suggest that these DELs were associated with the cellular response to inorganic substances, alkaloids, estradiols, reactive oxygen species, metal ions and oxidative stress. In particular, the heme oxygenase 1 (HO-1) gene participates in many of these functions. A multitude of pathways were implicated, including metabolic pathways, chemokine signaling pathways, malaria, Parkinson\'s disease and the cell cycle. Notably, the BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) and C-C motif chemokine ligand 2 (CCL2) genes were associated with the cell cycle.

### Regulatory analysis of DELs

A total of 91 *cis*-regulatory genes of 94 DELs, including 55 upregulated lncRNAs in the MCAO group were identified; 14 of the 91 *cis*-regulatory genes exhibited differential expression. A total of 13 of the DEL/*cis*-regulatory gene pairs had positive correlations as follows: NONRATT021925.2 (Rho GDP dissociation inhibitor β), NONRATT004791.2 (G protein subunit γ transducing 2), NONRATT015286.2 (periostin), MSTRG.30235.10 (LRR binding FLII interacting protein 1), NONRATT015403.2 (IQ motif containing GTPase activating protein 3), NONRATT008267.2 (kinesin family member 14), NONRATT009960.2 (non-SMC condensin I complex subunit G), NONRATT011312.2 (retinol binding protein 3), NONRATT005985.2 (DNA topoisomerase IIα), NONRATT016680.2 (ENSRNOG00000053081), NONRATT013960.2 (galanin receptor 1), NONRATT016022.2 (CART prepropeptide) and NONRATT024616.2 (δ like non-canonical Notch ligand 1) ([Table III](#tIII-mmr-20-01-0417){ref-type="table"}). Additionally, 90 *trans*-regulatory genes of lncRNAs were filtered by BLASTN and RNAplex, with a negative correlation identified between ENSRNOT00000092040 and Ccl9 ([Table IV](#tIV-mmr-20-01-0417){ref-type="table"}).

### Validation of expression of DELs by RT-qPCR

From the data in [Fig. 6](#f6-mmr-20-01-0417){ref-type="fig"}, NONRATT027551.2, MSTRG.1836.1 and MSTRG.4344.10 were identified to be significantly upregulated in the MCAO group compared with the control (P\<0.05), consistent with the RNA-seq data, while MSTRG.7720.11, NONRATT005132.2 and MSTRG.20633.3 were significantly downregulated in the MCAO group compared with the control (P\<0.01), also consistent with the RNA-seq data. These results, revealing that the RNA-seq results were consistent with the RT-qPCR results, verified that the RNA-seq results were reliable ([Fig. 6](#f6-mmr-20-01-0417){ref-type="fig"}).

Discussion
==========

A host of lncRNAs have been indicated to be involved in ischemic stroke by microarray or RNA-seq studies ([@b35-mmr-20-01-0417],[@b36-mmr-20-01-0417]). Metastasis associated lung adenocarcinoma transcript 1 was identified to have a function in ischemic stroke through inhibiting endothelial cell death and inflammation ([@b36-mmr-20-01-0417],[@b37-mmr-20-01-0417]). Additionally, the upregulation of H19 imprinted maternally expressed transcript may induce apoptosis and necrosis in cerebral ischemic reperfusion injury ([@b38-mmr-20-01-0417]--[@b40-mmr-20-01-0417]). In the present study, a total of 77 upregulated and 57 downregulated DELs (\|FC\|\>2, P\<0.05) were identified through reliable RNA-seq and validated using RT-qPCR in an ischemic stroke group induced by MCAO compared with a control group.

HO-1-mediated neurogenesis has been demonstrated to be enhanced in ischemic stroke in mice ([@b41-mmr-20-01-0417]). HO-1 has been revealed to promote angiogenesis following cerebral ischemic reperfusion injury in rats ([@b42-mmr-20-01-0417]). GO enrichment analysis suggested that HO-1 was associated with responses to alkaloids, cellular responses to oxidative stress and responses to reactive oxygen species. BUB1B has been reported to promote tumor proliferation in glioblastoma ([@b43-mmr-20-01-0417],[@b44-mmr-20-01-0417]). Similarly, BUB1B has been implicated in tumor growth and the progression of prostate cancer ([@b45-mmr-20-01-0417]), and overexpressed BUB1B has been demonstrated to be involved in lung adenocarcinoma in humans ([@b46-mmr-20-01-0417]). The KEGG enrichment analysis in the present study indicated that BUB1B was associated with the cell cycle. It has previously been reported that upregulated CCL2 is associated with protection from stroke induced by hypoxic preconditioning ([@b47-mmr-20-01-0417]), and the knockdown of CCL2 was used to successfully reverse the drug resistance of tumor cells in gastric cancer ([@b48-mmr-20-01-0417]). In the KEGG enrichment analysis performed in the present study, CCL2 was additionally associated with the cell cycle. Furthermore, based on the data presented in [Fig. 3](#f3-mmr-20-01-0417){ref-type="fig"}, HO-1, BUB1B and CCL2 may be regulated by a number of novel lncRNAs, including NONRATT008267.2, NONRATT015286.2, NONRATT004791.2, MSTRG.15067.2, NONRATT003289.2, NONRATT004566.2, NONRATT005985.2, NONRATT008198.2, NONRATT028439.2, NONRATT026753.2, NONRATT027268.2, MSTRG.15418.3, NONRATT016680.2, NONRATT015403.2, MSTRG.29693.5, NONRATT009960.2, MSTRG.27670.3 and NONRATT000377.2. A previous study has suggested that the knockdown of DNA topoisomerase IIα (Top2a) may suppress proliferation and invasion of colon cancer cells ([@b49-mmr-20-01-0417]); based on the present regulatory analysis of DELs, Top2a, as a *cis*-regulatory gene of NONRATT005985.2, may have a vital function in ischemic stroke. Overall, the analyzed data provide novel DELs and an lncRNA-mRNA regulatory network that may provide a better understanding of ischemic stroke induced by MCAO.
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![Class type and chromosome distribution of lncRNAs identified in the control and MCAO group. (A) Venn diagram of lncRNA in the control and MCAO groups. (B) According to the positional association between lncRNA and mRNA in the genome, lncRNAs may be classified into six types: Bidirectional, exonic antisense, exonic sense, intergenic, intronic antisense and intronic sense. (C) Number of lncRNAs on each chromosome in the MCAO and control groups. MCAO, Middle cerebral artery occlusion; lncRNA, long noncoding RNA.](MMR-20-01-0417-g00){#f1-mmr-20-01-0417}

![RNA-seq data on the differentially expressed lncRNAs between the model and control groups. (A) Hierarchical cluster of DELs between the MCAO and control groups. The color code in each heat map is linear, with green indicating the least and red indicating the greatest differentiation. The mean signals of the altered lncRNAs in each of the two groups were clustered using a Euclidean distance function. The lncRNAs with the most similar expression patterns were placed next to each other (n=3 per group). (B) A volcano plot of the RNA-seq FC and P-value of MCAO group compared with the control group. Blue and red points stand for DELs. Gray points represent lncRNAs which are not differentially expressed. (C) Upregulated and (D) downregulated DELs as exhibited in the red and blue boxes, respectively, represent the results. MCAO, Middle cerebral artery occlusion; lncRNA, long noncoding RNA; RNA-seq, RNA sequencing; FC, fold change; DEL, differentially expressed lncRNAs.](MMR-20-01-0417-g01){#f2-mmr-20-01-0417}

![An lncRNA-gene-network based on Pearson\'s correlation coefficient. Pink nodes indicate the upregulated mRNAs or lncRNAs, and green nodes indicate the downregulated mRNAs or lncRNAs. lncRNA, long noncoding RNA.](MMR-20-01-0417-g02){#f3-mmr-20-01-0417}

![Top 30 significant enrichment of GO terms in the long noncoding RNA-mRNA network. GO, gene ontology; ERK, extracellular regulated kinase.](MMR-20-01-0417-g03){#f4-mmr-20-01-0417}

![Top 30 significant enrichment of KEGG pathway terms in the long noncoding RNA-mRNA network. KEGG, Kyoto Encyclopedia of Genes and Genomes; TNF, tumor necrosis factor; HIF-1, hypoxia-inducible factor 1; ECM, extracellular matrix.](MMR-20-01-0417-g04){#f5-mmr-20-01-0417}

![Validation of lncRNA RNA-seq data by RT-qPCR. Fold changes represent the comparison of the MCAO group with the control group. Blue bars indicate the fold change were detected with RNA-seq. \*\*P\<0.01 vs. the control group. The orange bars indicate the fold change detected using RT-qPCR. ^\$^P\<0.05 and ^\$\$^P\<0.01 vs. the control group. Comparison of the results obtained from RT-qPCR and RNA-seq revealed satisfactory consistency (R^2^=0.9338). MCAO, Middle cerebral artery occlusion; lncRNA, long noncoding RNA; RNA-seq, RNA sequencing; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.](MMR-20-01-0417-g05){#f6-mmr-20-01-0417}

###### 

Primer sequences.

  Gene              Sequence                         Polymerase chain reaction product length (base pairs)
  ----------------- -------------------------------- -------------------------------------------------------
  GAPDH             F: 5′-CCTGGTATGACAACGAATTTG-3′   131
                    R: 5′-CAGTGAGGGTCTCTCTCTTCC-3′   
  NONRATT027551.2   F: 5′- GGACCTGGAAGGTGAACAGG-3′   118
                    R: 5′-TGAATGGGTGACCAACAGGG-3′    
  MSTRG.1836.1      F: 5′-CCATTGTCCTTCCATCCCCC-3′    85
                    R: 5′-CCACCCTACCAAACTTCCCC-3′    
  MSTRG.4344.10     F: 5′-GACTTAGGCACAGTGGGTGG-3′    119
                    R: 5′-ATGGCAGAGAGCGAATGGAG-3′    
  MSTRG.7720.11     F: 5′-TCCCTAGAGCAGTCCTCACC-3′    97
                    R: 5′- ATCTCGGGTTCGCCTTTTGT-3′   
  NONRATT005132.2   F: 5′-CCTGACTATGGCACGTCCTC-3′    152
                    R: 5′-CTGAGTCCAGTGTGCCTGTT-3′    
  MSTRG.20633.3     F: 5′-CTTTCACTCCGAGAACCCCC-3′    117
                    R: 5′-GCAAGCAGGTTGGTTCCTTG-3′    

F, forward; R, reverse.

###### 

Results of the RNA sequencing.

  Sample ID   Raw reads   Clean reads   Clean ratio (%)   rRNA trimmed   Mapped reads   Mapped ratio
  ----------- ----------- ------------- ----------------- -------------- -------------- --------------
  MCAO 1      155190870   147282901     94.90             147214274      131290423      0.824026529
  MCAO 2      144450130   136930064     94.79             136768708      120311195      0.812346697
  MCAO 3      151411986   142862439     94.35             142724911      125540743      0.804354762
  Control 1   169303916   160544960     94.83             160466568      142289885      0.819832697
  Control 2   136533930   129672892     94.97             129609605      116072061      0.828973282
  Control 3   124878376   118432971     94.84             118349299      105506286      0.821661742

MCAO, middle cerebral artery occlusion.

###### 

Differentially expressed lncRNAs mechanisms involved in *cis*-regulatory elements.

  lncRNA ID         log2FC   Q value   Up/downregulated   Type    Gene ID              Gene name        log2FC   P-value   Up/downregulated
  ----------------- -------- --------- ------------------ ------- -------------------- ---------------- -------- --------- ------------------
  NONRATT017723.2   −3.68    0.0125    Down               *cis*   ENSRNOG00000000633   Rhobtb1          0.85     0.1148    --
  NONRATT008064.2   −6.73    0.0145    Down               *cis*   ENSRNOG00000001183   Hnf1a            1.25     0.7907    --
  NONRATT000377.2   +∞       0.0492    Up                 *cis*   ENSRNOG00000001492   Slc8a2           0.13     0.9091    --
  NONRATT006957.2   6.69     0.0000    Up                 *cis*   ENSRNOG00000001982   Cblb             0.60     0.1402    --
  NONRATT009831.2   −5.72    0.0425    Down               *cis*   ENSRNOG00000002137   Aasdh            0.21     0.7048    --
  NONRATT009718.2   −5.48    0.0020    Down               *cis*   ENSRNOG00000002146   Pkd2             0.29     0.5035    --
  NONRATT009780.2   −3.94    0.0473    Down               *cis*   ENSRNOG00000002208   Shroom3          0.83     0.1301    --
  NONRATT005026.2   6.14     0.0000    Up                 *cis*   ENSRNOG00000002607   Sox9             0.25     0.5566    --
  NONRATT014565.2   −2.91    0.0492    Down               *cis*   ENSRNOG00000002864   Nacc1            0.26     0.5744    --
  NONRATT005048.2   -∞       0.0432    Down               *cis*   ENSRNOG00000003144   Gprc5c           0.48     0.5195    --
  NONRATT024547.2   -∞       0.0082    Down               *cis*   ENSRNOG00000003955   Spata7           0.26     0.6325    --
  NONRATT026753.2   3.08     0.0450    Up                 *cis*   ENSRNOG00000003993   Thap2            0.26     0.7629    --
  NONRATT005132.2   −8.71    0.0471    Down               *cis*   ENSRNOG00000004049   Baiap2           −0.04    0.8211    --
  NONRATT026300.2   +∞       0.0469    Up                 *cis*   ENSRNOG00000004628   Dazap2           0.13     0.8554    --
  NONRATT026156.2   7.44     0.0000    Up                 *cis*   ENSRNOG00000005332   Csdc2            −0.58    0.1263    --
  NONRATT005775.2   3.69     0.0453    Up                 *cis*   ENSRNOG00000005538   Psmd11           −0.03    0.7616    --
  NONRATT023334.2   −4.85    0.0448    Down               *cis*   ENSRNOG00000005711   Ptprd            −0.21    0.4658    --
  NONRATT021925.2   +∞       0.0000    Up                 *cis*   ENSRNOG00000005809   Arhgdib          1.81     0.0074    Up
  NONRATT004791.2   4.02     0.0218    Up                 *cis*   ENSRNOG00000006108   Gngt2            4.95     0.0000    Up
  MSTRG.22811.4     -∞       0.0388    Down               *cis*   ENSRNOG00000006966   Nfia             0.21     0.6590    --
  NONRATT025479.2   −4.14    0.0000    Down               *cis*   ENSRNOG00000007610   Gdf11            0.08     0.9402    --
  NONRATT020232.2   −7.72    0.0000    Down               *cis*   ENSRNOG00000007804   C1galt1          0.45     0.2729    --
  NONRATT008198.2   4.83     0.0305    Up                 *cis*   ENSRNOG00000007887   Elk4             0.76     0.2762    --
  NONRATT022252.2   +∞       0.0305    Up                 *cis*   ENSRNOG00000008099   Galnt12          0.85     0.2496    --
  NONRATT024954.2   −3.98    0.0471    Down               *cis*   ENSRNOG00000008155   Dus4l            −0.17    0.7340    --
  NONRATT028439.2   5.06     0.0430    Up                 *cis*   ENSRNOG00000008187   Ubash3b          −0.21    0.4764    --
  NONRATT022210.2   −4.24    0.0492    Down               *cis*   ENSRNOG00000008237   Unc13b           0.30     0.6027    --
  NONRATT027551.2   9.08     0.0119    Up                 *cis*   ENSRNOG00000008709   Arhgap32         −0.24    0.5090    --
  NONRATT027576.2   -∞       0.0061    Down               *cis*   ENSRNOG00000008757   Tmem218          0.16     0.8511    --
  NONRATT021402.2   -∞       0.0291    Down               *cis*   ENSRNOG00000009156   Tra2a            0.47     0.2267    --
  NONRATT021972.2   +∞       0.0335    Up                 *cis*   ENSRNOG00000009338   Kras             −0.11    0.6201    --
  NONRATT022345.2   −5.23    0.0000    Down               *cis*   ENSRNOG00000009795   Nfib             0.04     0.9239    --
  MSTRG.16900.3     −4.70    0.0248    Down               *cis*   ENSRNOG00000009882   Ppp3ca           0.07     1.0000    --
  MSTRG.19870.10    +∞       0.0000    Up                 *cis*   ENSRNOG00000010993   Dpm1             −0.14    0.5966    --
  NONRATT008272.2   −3.96    0.0431    Down               *cis*   ENSRNOG00000011063   Dennd1b          0.20     0.7240    --
  MSTRG.10245.2     6.31     0.0002    Up                 *cis*   ENSRNOG00000011704   Fbxo34           −0.37    0.2745    --
  NONRATT001841.2   3.41     0.0430    Up                 *cis*   ENSRNOG00000012110   Col17a1          −1.52    0.0483    Down
  NONRATT002035.2   7.89     0.0003    Up                 *cis*   ENSRNOG00000012324   Soga3            −0.04    0.7913    --
  MSTRG.22390.2     -∞       0.0000    Down               *cis*   ENSRNOG00000012634   Fbxo10           −0.41    0.1989    --
  MSTRG.22390.1     +∞       0.0000    Up                 *cis*   ENSRNOG00000012634   Fbxo10           −0.41    0.1989    --
  NONRATT015286.2   5.30     0.0425    Up                 *cis*   ENSRNOG00000012660   Postn            3.66     0.0004    Up
  MSTRG.1836.3      −7.60    0.0041    Down               *cis*   ENSRNOG00000012716   Chd2             0.06     0.9929    --
  MSTRG.1836.1      9.24     0.0001    Up                 *cis*   ENSRNOG00000012716   Chd2             0.06     0.9929    --
  NONRATT016334.2   +∞       0.0000    Up                 *cis*   ENSRNOG00000012734   Dcun1d1          −0.20    0.5140    --
  NONRATT015057.2   −4.70    0.0049    Down               *cis*   ENSRNOG00000012799   Prkaa1           −0.28    0.3193    --
  NONRATT000212.2   −6.12    0.0378    Down               *cis*   ENSRNOG00000013194   Rps6ka2          −0.14    0.5704    --
  NONRATT030198.2   5.34     0.0000    Up                 *cis*   ENSRNOG00000013213   Epha4            0.35     0.5640    --
  NONRATT010352.2   −6.23    0.0004    Down               *cis*   ENSRNOG00000013353   Tmem260          0.07     0.9952    --
  NONRATT029471.2   4.91     0.0082    Up                 *cis*   ENSRNOG00000013557   Lancl1           −0.17    0.5373    --
  NONRATT028588.2   6.05     0.0378    Up                 *cis*   ENSRNOG00000013829   Chrna3           1.17     0.2523    --
  NONRATT023203.2   +∞       0.0007    Up                 *cis*   ENSRNOG00000013956   Rnf38            0.17     0.7841    --
  MSTRG.29693.5     +∞       0.0484    Up                 *cis*   ENSRNOG00000013991   Creg2            −0.69    0.2339    --
  MSTRG.12408.2     -∞       0.0041    Down               *cis*   ENSRNOG00000014007   Gfod1            0.04     0.9704    --
  NONRATT004566.2   3.44     0.0440    Up                 *cis*   ENSRNOG00000015002   Abhd15           0.76     0.3266    --
  MSTRG.15067.2     +∞       0.0090    Up                 *cis*   ENSRNOG00000015334   Fcho2            0.49     0.2280    --
  NONRATT003289.2   7.56     0.0052    Up                 *cis*   ENSRNOG00000015717   Ptpre            0.21     0.6977    --
  NONRATT013960.2   −3.81    0.0248    Down               *cis*   ENSRNOG00000016654   Galr1            −3.38    0.0001    Down
  NONRATT028604.2   4.71     0.0000    Up                 *cis*   ENSRNOG00000017193   Lingo1           −0.52    0.2454    --
  NONRATT016022.2   −5.74    0.0001    Down               *cis*   ENSRNOG00000017712   Cartpt           −3.83    0.0001    Down
  NONRATT015604.2   −5.60    0.0000    Down               *cis*   ENSRNOG00000018166   Prkab2           0.00     0.8495    --
  NONRATT024616.2   −3.79    0.0143    Down               *cis*   ENSRNOG00000019584   Dlk1             −4.21    0.0000    Down
  MSTRG.30235.10    8.50     0.0275    Up                 *cis*   ENSRNOG00000019892   Lrrfip1          1.14     0.0479    Up
  NONRATT026461.2   +∞       0.0118    Up                 *cis*   ENSRNOG00000020230   Pias4            0.17     0.8050    --
  NONRATT018820.2   -∞       0.0002    Down               *cis*   ENSRNOG00000020337   Sla2             0.52     0.5953    --
  NONRATT004912.2   6.00     0.0041    Up                 *cis*   ENSRNOG00000020658   Aarsd1           0.05     0.9927    --
  NONRATT019712.2   −6.20    0.0446    Down               *cis*   ENSRNOG00000021262   Slc23a2          0.09     0.9742    --
  NONRATT027268.2   5.27     0.0071    Up                 *cis*   ENSRNOG00000022570   Pus7l            0.51     0.5096    --
  MSTRG.12863.69    +∞       0.0304    Up                 *cis*   ENSRNOG00000023661   Celf2            0.30     0.5495    --
  NONRATT030368.2   5.55     0.0043    Up                 *cis*   ENSRNOG00000025527   Mtcl1            0.16     0.8136    --
  NONRATT027862.2   −3.75    0.0304    Down               *cis*   ENSRNOG00000027145   Rora             −0.16    0.5963    --
  NONRATT015403.2   4.83     0.0409    Up                 *cis*   ENSRNOG00000027894   Iqgap3           2.03     0.0137    Up
  NONRATT003576.2   +∞       0.0028    Up                 *cis*   ENSRNOG00000028017   Tmem109          0.36     0.4097    --
  NONRATT004361.2   −5.86    0.0409    Down               *cis*   ENSRNOG00000028341   Alkbh5           0.00     0.8591    --
  NONRATT012903.2   −5.26    0.0000    Down               *cis*   ENSRNOG00000031706   AABR07027388.1   −0.85    0.1761    --
  MSTRG.15111.2     +∞       0.0000    Up                 *cis*   ENSRNOG00000032735   Srek1            0.18     0.7203    --
  MSTRG.15111.1     −7.42    0.0000    Down               *cis*   ENSRNOG00000032735   Srek1            0.18     0.7203    --
  NONRATT028102.2   10.21    0.0000    Up                 *cis*   ENSRNOG00000033809   Mlh1             0.76     0.1272    --
  NONRATT019889.2   −4.60    0.0113    Down               *cis*   ENSRNOG00000034031   Vstm2l           −0.45    0.3771    --
  NONRATT008267.2   +∞       0.0039    Up                 *cis*   ENSRNOG00000037211   Kif14            5.80     0.0005    Up
  NONRATT009960.2   4.06     0.0430    Up                 *cis*   ENSRNOG00000038572   Ncapg            3.28     0.0054    Up
  MSTRG.21884.7     +∞       0.0492    Up                 *cis*   ENSRNOG00000042458   Stau2            −0.20    0.5104    --
  NONRATT030464.2   5.30     0.0042    Up                 *cis*   ENSRNOG00000046053   Nudt10           −0.59    0.1573    --
  MSTRG.15418.3     +∞       0.0448    Up                 *cis*   ENSRNOG00000048993   Metazoa_SRP      0.03     0.9881    --
  MSTRG.28323.2     +∞       0.0492    Up                 *cis*   ENSRNOG00000049584   AABR07070555.1   −0.13    0.8591    --
  MSTRG.4080.13     +∞       0.0002    Up                 *cis*   ENSRNOG00000049768   Adcy9            −0.04    0.7770    --
  NONRATT025333.2   6.61     0.0000    Up                 *cis*   ENSRNOG00000051719   AABR07065498.1   0.11     0.9304    --
  NONRATT011312.2   +∞       0.0479    Up                 *cis*   ENSRNOG00000051911   Rbp3             9.84     0.0000    Up
  NONRATT024648.2   -∞       0.0492    Down               *cis*   ENSRNOG00000052540   SNORD113         0.45     0.6631    --
  NONRATT005985.2   4.53     0.0490    Up                 *cis*   ENSRNOG00000053047   Top2a            5.28     0.0000    Up
  NONRATT016680.2   7.62     0.0041    Up                 *cis*   ENSRNOG00000053081                    3.59     0.0011    Up
  NONRATT009382.2   8.35     0.0257    Up                 *cis*   ENSRNOG00000056826   Arap2            0.21     0.6941    --
  MSTRG.15263.2     -∞       0.0041    Down               *cis*   ENSRNOG00000060329   Emb              −0.06    0.7939    --
  NONRATT015639.2   3.25     0.0005    Up                 *cis*   ENSRNOG00000061058   Csde1            0.02     0.8739    --
  NONRATT027585.2   7.19     0.0000    Up                 *cis*   ENSRNOG00000061656   SNORD14          0.17     0.9160    --

lncRNA, long noncoding RNA; FC, fold change.

###### 

Differentially expressed lncRNA mechanisms involved in t*rans*-regulatory elements.

  lncRNA ID            log2FC   Q value   Up/downregulated   Type            Gene name    log2FC   P-value   Up/downregulated
  -------------------- -------- --------- ------------------ --------------- ------------ -------- --------- ------------------
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ccl9         5.19     0.0017    Up
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Homer3       1.00     0.0611    --
  ENSRNOT00000088402   +∞       0.0471    Up                 Trans           Aurkb        2.35     0.0723    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Galns        1.03     0.0724    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Slc39a1      0.92     0.0739    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           AC099384.2   +∞       0.1052    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Hsd3b7       0.83     0.1369    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Klrb1b       1.98     0.1413    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Me2          0.63     0.1558    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Pnma2        −0.51    0.1564    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Cass4        1.24     0.1599    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Klhl23       −0.44    0.2192    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Elac1        −0.49    0.2260    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Clcf1        1.26     0.2519    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Fzd6         0.80     0.2590    --
  NONRATT009960.2      4.06     0.0430    Up                 Trans           Lcorl        −0.44    0.3199    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Gpr37l1      0.40     0.3297    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Mmab         −0.35    0.3391    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Spon1        −0.28    0.3414    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ifngr2       0.44     0.3660    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Foxred2      −0.35    0.3732    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Prr22        −0.67    0.3889    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Sppl2a       0.40     0.3894    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Haus5        0.55     0.4019    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Cpvl         0.80     0.4041    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Fam120b      −0.24    0.4061    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Fbxo3        −0.21    0.4206    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ypel4        −0.24    0.4477    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Klhl26       −0.20    0.4480    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Sync         0.43     0.5076    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Lhfpl5       −0.31    0.5231    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Mrpl52       0.44     0.5306    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Cldn15       −0.39    0.5315    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Mrps35       −0.18    0.5443    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Zfp382       −0.17    0.5640    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ube2k        −0.14    0.5697    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Drg1         −0.12    0.5755    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           P2rx5        −0.36    0.5770    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Xpnpep3      0.25     0.5933    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           RGD1311345   0.28     0.5950    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Acer2        0.32     0.6034    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Urgcp        0.28     0.6182    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Megf8        −0.10    0.6223    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Lrtm2        −0.14    0.6301    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           RGD1562299   0.26     0.6325    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Rpl9         0.38     0.6347    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Slc25a44     −0.10    0.6348    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ssmem1       −0.28    0.6350    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Stt3a        0.24     0.6468    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Spire1       −0.09    0.6631    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           RGD1561777   −0.13    0.6846    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Luzp1        −0.09    0.6941    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Acot2        0.26     0.7000    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Fitm2        −0.07    0.7111    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Aox4         0.32     0.7374    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Golga1       −0.04    0.7775    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Lefty2       1.23     0.7977    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Zdhhc24      −0.04    0.8075    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Zfp329       −0.03    0.8205    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Tmem101      −0.03    0.8236    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Dhh          0.28     0.8353    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ncr3         0.57     0.8354    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ppp1r15b     0.14     0.8423    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Zfyve27      −0.01    0.8439    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ints7        0.15     0.8457    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Dus1l        0.14     0.8545    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ahsa2        0.15     0.8576    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Aif1l        0.15     0.8579    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Rsg1         0.16     0.8645    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Fuom         0.15     0.8883    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Cwf19l1      0.12     0.8894    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Paqr7        0.01     0.8942    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Coa5         0.02     0.8985    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Cdc14b       0.13     0.8989    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Crebl2       −0.01    0.9081    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           RGD1564541   0.10     0.9210    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Slc15a1      −0.03    0.9211    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Ppm1k        0.03     0.9299    --
  NONRATT025479.2      −4.14    0.0000    Down               Cis and trans   Gdf11        0.08     0.9402    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Fam20b       0.04     0.9436    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Anapc11      0.09     0.9536    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Tmem79       −0.04    0.9595    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Cwc25        0.06     0.9692    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Blvrb        0.07     0.9859    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Stk4         0.08     0.9880    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Rbm20        0.08     0.9896    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Tbc1d10b     0.06     0.9927    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Mapkbp1      0.07     0.9986    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Psma8        1.00     1.0000    --
  ENSRNOT00000092040   −3.35    0.0204    Down               Trans           Rbbp8nl      0.37     1.0000    --

lncRNA, long non-coding RNA; FC, fold change.
